Runben Biotechnology Co., Ltd. (SHA:603193)

China · Delayed Price · Currency is CNY

26.62

+0.65 (2.50%)

May 6, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Personal Products		1.32B	1.03B	856.09M	582.15M	442.83M
Personal Products Growth		27.61%	20.66%	47.06%	31.46%	58.93%
Total		1.32B	1.03B	856.09M	582.15M	442.83M
Total Growth		27.61%	20.66%	47.06%	31.46%	58.93%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
China		1.32B	1.03B	856.09M	582.15M	442.83M
China Growth		27.61%	20.66%	47.06%	31.46%	58.93%
Total		1.32B	1.03B	856.09M	582.15M	442.83M
Total Growth		27.61%	20.66%	47.06%	31.46%	58.93%

Source: S&P Global Market Intelligence.